OncoDNA is a Belgian theranostic company, founded in 2012, dedicated to helping laboratories, clinicians, and biopharma partners make better-informed decisions through advanced genomic insights. Our strength lies in our multi-dimensional expertise in centralised and decentralised solid tissue and liquid biopsy solutions underpinned by our bioinformatics and reporting software. OncoDNA supports customer to define their most effective testing strategy balancing the needs of the clinical context with local reimbursement arrangements. By combining advanced tissue and liquid molecular testing, bioinformatics, and interpretation tools, we deliver insights on cancer management from treatment selection to disease monitoring and management of disease recurrence. Our mission is to facilitate a personalized, evidence-based approach to creating treatment plans for oncology patients, ultimately improving cancer patients quality of life and outcomes. With a network of partner laboratories and distributors spanning Europe and beyond, OncoDNA ensures that wherever you are, you can access the tools and expertise needed to guide your care with confidence. Visit www.oncodna.com
Looking for a particular OncoDNA employee's phone or email?
The OncoDNA annual revenue was $5.9 million in 2026.
Koenraad Eycken is the Chief Product Offficer of OncoDNA.
31 people are employed at OncoDNA.
The NAICS codes for OncoDNA are [541713, 541, 5112, 511, 5417, 54171, 51, 54].
The SIC codes for OncoDNA are [73, 87, 873, 737].